Plus Therapeutics, Inc. (NASDAQ:PSTV) Receives Consensus Rating of "Moderate Buy" from Brokerages

Shares of Plus Therapeutics, Inc. (NASDAQ:PSTV - Get Free Report) have earned a consensus rating of "Moderate Buy" from the six analysts that are covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, four have issued a buy rating and